BYSI
BeyondSpring Inc.
There isn't enough reported data to score BYSI yet.
LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
BYSI Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
BYSI's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
BYSI PE Valuation
BYSI has no meaningful PE right now: it lost money over the past year.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
BYSI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong decline | |
| -- | |
| Limited | |
| High |
Analysts expect BYSI's losses to shrink, with revenue declining.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
BYSI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.16 | -$0.02 |
| Q1 2026 | -$0.24 | -$0.11 |
| Q4 2025 | -$0.08 | +$0.26 |
| Q3 2025 | -$0.07 | +$0.34 |
| Q2 2025 | -$0.14 | +$0.27 |
| Q1 2025 | -$0.13 | +$0.34 |
| Q4 2024 | -$0.34 | +$0.20 |
| Q3 2024 | -$0.41 | +$0.21 |
BYSI is still losing money, but far less than before: $0.16 per share over the past year, against $2.04 at its worst in late 2020.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over BYSI on earnings quality, reporting a profit while its opponent remains loss making.
BYSI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2024 | $500K | +14% |
| Q1 2024 | $500K | +14% |
| Q4 2023 | $438K | +30% |
| Q3 2023 | $438K | +30% |
| Q2 2023 | $437.5K | +29% |
| Q1 2023 | $437.5K | +29% |
| Q4 2022 | $337.5K | -0.1% |
| Q3 2022 | $337.5K | +0.1% |
BYSI's revenue has slid since its 2024 peak: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2024 | -742% | +799 points |
| Q1 2024 | -742% | +799 points |
| Q4 2023 | -1099% | +1335 points |
| Q3 2023 | -1099% | +1335 points |
| Q2 2023 | -1541% | +1537 points |
| Q1 2023 | -1541% | +1537 points |
| Q4 2022 | -2434% | +670 points |
| Q3 2022 | -2434% | +3011 points |
BYSI's operating margin was −742% last quarter, up 799 points from the same quarter a year ago.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over BYSI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY's operating margin was 34% last quarter, down 6.6 points from the same quarter a year ago.
BYSI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3.8M | +$2.1M |
| Q1 2026 | -$3.3M | +$971K |
| Q4 2025 | -$5.5M | -$5.5M |
| Q3 2025 | -$4.2M | -$4.2M |
| Q2 2025 | -$5.9M | -$5.9M |
| Q1 2025 | -$4.2M | -$4.2M |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
BYSI has burned cash in six of the last eight quarters: −$17M over the past year, against −$10M the year before.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over BYSI on cash generation, producing positive trailing cash flow while its opponent burns cash.
BYSI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +17 shares |
| 1 year | +2% | +804K shares |
| 3 years | +5.5% | +2.1M shares |
| 5 years | +5.4% | +2.1M shares |
| Available history | +62% | +15.8M shares |
BYSI has 41M diluted shares, up 2% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over BYSI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
BYSI Net Leverage
BYSI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
BYSI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.3 | Neutral |
| Stochastic | 21.8 | Neutral |
BYSI's weekly RSI is 36 (neutral) and its Stochastic is 22 (neutral).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
BYSI PE vs Healthcare Sector
BYSI has no meaningful PE right now: it lost money over the past year.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
BYSI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.63 | 4.8% below |
| 20 week MA | $0.86 | 30% below |
| 50 week MA | $1.33 | 55% below |
| 100 week MA | $1.58 | 62% below |
| 200 week MA | $1.61 | 63% below |
BYSI is in a downtrend: it's below all five of its weekly moving averages, and 63% below its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over BYSI on trend strength, trading above more of its moving averages.
BYSI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.9 | $11.1 | -30% |
| 2021 | $11.1 | $4.92 | -55% |
| 2022 | $4.92 | $1.69 | -66% |
| 2023 | $1.69 | $0.90 | -47% |
| 2024 | $0.90 | $1.62 | +80% |
| 2025 | $1.62 | $1.84 | +14% |
| 2026 YTD | $1.84 | $0.60 | -67% |
BYSI has finished lower in four of the last six years. It's down 67% so far in 2026.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over BYSI on returns for 2026, with the stronger performance.